ClinicalTrialsFinder
RecruitingNot ApplicableNCT04987073

Vitamin D Analog in Vitamin D 24-hydroxylase Deficiency

Preclinic Evaluation of a Vitamin D Analog in Vitamin D 24-hydroxylase Deficiency

Sponsor

University Hospital, Caen

Enrollment

30 participants

Start Date

Jul 17, 2022

Study Type

INTERVENTIONAL

Conditions

Idiopathic Infantile Hypercalcemia - Severe Form

Summary

Preclinical evaluation of a vitamin D analog for the treatment of vitamin D 24-hydroxylase using fibroblast from patients with CYP24A1 mutation.

Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • biallelic mutation in CYP24A1
  • consent

Exclusion Criteria1

  • none
Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREskin biopsy

A skin biopsy to cultivate fibroblasts.

Locations(1)

Arnaud Molin

Caen, Normandy, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04987073